[1]
2025. Development of Machine Learning Platforms that Accelerate Drug Discovery and Molecular Screening for Cancers, Autoimmune Diseases, And Neurological Disorders. American Journal of Engineering , Mechanics and Architecture (2993-2637). 3, 12 (Dec. 2025), 8–18.